60 / 68
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015
e10
AFRICA
Conclusion
VSD is a rare complication of TAVI and can occur without post-
balloon dilatation, heavy calcification or oversizing of the valve.
Although it is a serious problem, asymptomatic presentation
may occur and routine careful TTE examination after TAVI is
very important. Percutaneous treatment of this complication
should not be thought of as a routine VSD occlusion procedure,
and a cardiac team should be ready for implantation of a second
valve. Opening of the occluder device in the ascending aorta may
be done without any damage to the bioprosthetic aortic valve.
References
1.
Masson BJ, Kovac J, Schuler G,
et al.
Transcatheter aortic valve implan-
tation: review of the nature, management, and avoidance of procedural
complications.
J Am Coll Cardiol Interv
2009;
2
(9): 811–820.
2.
Vallabhajosyula P, Bavaria JE. Transcatheter aortic valve implanta-
tion: Complications and management.
J Heart Valve Dis
2011;
20
(5):
499–509.
3.
Gerckens U, Latsios G, Pizzulli L. Percutaneous treatment of a post-
TAVI ventricular septal defect: a successful combined procedure for an
unusual complication.
Catheter Cardiovasc Interv
2013;
81
: 274–277.
4.
J Blumenstein, A Van Linden, M Arsalan,
et al
. Ventricular septum
defect after TAVI: Rare but happens.
Thorac Cardiovasc Surg
2013;
61
:
SC21.
5.
Aminian A, Lalmand J, Dolatabadi D. Late contained aortic root
rupture and ventricular septal defect after transcatheter aortic valve
implantation.
Catheter Cardiovasc Interv
2013;
81
: 72–75.
6.
Tzikas A, Schultz C, Piazza N,
et al
. Perforation of the membranous
interventricular septum after transcatheter aortic valve implantation.
Circ Cardiovasc Interv
2009;
2
: 582–583.
7.
Pikaluk RD, Grocott PH. Aorta–RV fistula and VSD following tran-
scatheter aortic valve implantation. Abstract retrieved from Abstracts
in 35th Annual Meeting of Society of Cardiovascular Anesthesiologists
6–10 April 2013, Miami, Florida, USA.